Expert analysis on NDCT Rules 2026, GAMP 5 compliance, and the evolving landscape of drug safety in India.
CPHI & PMEC China 2026, scheduled from June 16–18, 2026 in Shanghai, will bring together pharmaceutical manufacturers, biotechnology innovators, CROs, CDMOs, ...
Read Analysis →
The landscape of Indian clinical research and drug manufacturing changed fundamentally on January 20, 2026. With the notification of the New Drugs and Clinical ...
Read Analysis →
The Indian pharmaceutical sector is undergoing a seismic shift. With the November 2025 mandates regarding QR codes for direct adverse event reporting, the volum...
Read Analysis →